SUN PHARMA
The stock recently got good healthy retracement from 61.8% which is good sign for trend continuation.
Within wave 5, wave I and II looks complete, and now possibly wave III can unfold towards 921, on down side 777 level will be crucial support to watch out for on the way down, the quarterly result is due on monday and hence there could be some volatility however, wave structure suggests wave III of 5 can now possibly unfold.
overall wave counts
Healthy retracement up to 0.618%
breakout with volume
macd in daily
macd in hourly
rsi in daily
rsi in hourly
Disclaimer.
I am not sebi registered analyst.
My studies are for educational purpose only.
Please Consult your financial advisor before trading or investing.
I am not responsible for any kinds of your profits and your losses.
Within wave 5, wave I and II looks complete, and now possibly wave III can unfold towards 921, on down side 777 level will be crucial support to watch out for on the way down, the quarterly result is due on monday and hence there could be some volatility however, wave structure suggests wave III of 5 can now possibly unfold.
overall wave counts
Healthy retracement up to 0.618%
breakout with volume
macd in daily
macd in hourly
rsi in daily
rsi in hourly
Disclaimer.
I am not sebi registered analyst.
My studies are for educational purpose only.
Please Consult your financial advisor before trading or investing.
I am not responsible for any kinds of your profits and your losses.
YouTube: youtube.com/@rk_charts
Telegram : t.me/RK_Charts
Twitter : @charts_rk
Email : rkcharts@gmail. com
Disclaimer.
I am not sebi registered analyst.
My studies are for educational purpose only.
Telegram : t.me/RK_Charts
Twitter : @charts_rk
Email : rkcharts@gmail. com
Disclaimer.
I am not sebi registered analyst.
My studies are for educational purpose only.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.